<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26-pharmaceuticals-14-00381">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vachon</surname>
    <given-names>M.-L.</given-names>
   </name>
   <name>
    <surname>Dionne</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Leblanc</surname>
    <given-names>Ã‰.</given-names>
   </name>
   <name>
    <surname>Moisan</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Bergeron</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Boivin</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Human parainfluenza type 4 infections, Canada</article-title>
  <source>Emerg. Infect. Dis.</source>
  <year>2006</year>
  <volume>12</volume>
  <fpage>1755</fpage>
  <pub-id pub-id-type="doi">10.3201/eid1211.060196</pub-id>
  <?supplied-pmid 17283630?>
  <pub-id pub-id-type="pmid">17283630</pub-id>
 </element-citation>
</ref>
